Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peiyuan Guben Tongluo Ointment is a Traditional Chinese Medicine (TCM) formulation developed by Shanghai Yueyang Integrated Medicine Hospital for the treatment of sarcopenia in elderly patients, specifically those presenting with Spleen-Kidney Deficiency Syndrome. The preparation is a "Gao Fang" (concentrated herbal paste) that incorporates ingredients such as Ejiao (donkey-hide gelatin). It is designed to "cultivate the origin" (Peiyuan) and "consolidate the root" (Guben) while improving circulation through the collaterals (Tongluo). Clinical evaluation focuses on its ability to increase limb muscle mass, as measured by dual-energy X-ray absorptiometry (DXA), and improve physical performance in the elderly population.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Peiyuan Guben Tongluo Ointment.